Page last updated: 2024-08-17

quinidine and oxprenolol

quinidine has been researched along with oxprenolol in 21 studies

Research

Studies (21)

TimeframeStudies, this research(%)All Research%
pre-199010 (47.62)18.7374
1990's0 (0.00)18.2507
2000's5 (23.81)29.6817
2010's6 (28.57)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Topliss, JG; Yoshida, F1
Alvarez-Pedraglio, A; Colmenarejo, G; Lavandera, JL1
Abraham, MH; Acree, WE; Ibrahim, A1
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM1
Du-Cuny, L; Mash, EA; Meuillet, EJ; Moses, S; Powis, G; Song, Z; Zhang, S1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Campillo, NE; Guerra, A; Páez, JA1
García-Mera, X; González-Díaz, H; Prado-Prado, FJ1
Ahlin, G; Bergström, F; Bredberg, U; Fridén, M; Hammarlund-Udenaes, M; Rehngren, M; Wan, H1
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K1
Bellman, K; Knegtel, RM; Settimo, L1
Atsmon, A; Epstein, O; Schoenfeld, N2
Camerini, F; Crepaldi, L; Martinoli, E; Medugno, G; Scardi, S1
Januskevicius, ZI; Zabela, PV; Zemaityte, DI1
Araú, A; Bonhorst, D; Bordalo, A; De Azevedo, JG; Ferreira, M; Ferreira, R; Inês, L; Lacximy, I; Longo, A; Luis Martins, J; Melo, M; Nunes Diogo, A; Ribeiro, C; Sanches, C; Teixeira, J1
Gettes, LS1
Singh, BN1
Gibson, DG1
Fitzgerald, JD; Wale, J1
Platek, H1

Reviews

3 review(s) available for quinidine and oxprenolol

ArticleYear
Beta adrenergic blocking drugs in the treatment of cardiac arrhythmias.
    Cardiovascular clinics, 1970, Volume: 2, Issue:2

    Topics: Adrenergic beta-Antagonists; Alprenolol; Arrhythmia, Sinus; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Digitalis Glycosides; Drug Therapy, Combination; Heart Conduction System; Heart Rate; Humans; Isoproterenol; Myocardial Infarction; Oxprenolol; Physical Exertion; Propranolol; Quinidine; Receptors, Adrenergic; Sotalol; Tachycardia, Paroxysmal

1970
Pharmacodynamic properties of beta-adrenergic receptor blocking drugs in man.
    Drugs, 1974, Volume: 7, Issue:1

    Topics: Adrenergic beta-Antagonists; Alprenolol; Blood Pressure; Cardiac Output; Catecholamines; Glycolysis; Heart; Heart Conduction System; Heart Rate; Hemodynamics; Humans; Lipid Metabolism; Oxprenolol; Oxygen Consumption; Physical Exertion; Pindolol; Practolol; Propranolol; Quinidine; Receptors, Adrenergic; Regional Blood Flow; Renin; Structure-Activity Relationship; Vasomotor System

1974
[Anti-arrhythmic drugs].
    Wiadomosci lekarskie (Warsaw, Poland : 1960), 1973, Apr-01, Volume: 26, Issue:7

    Topics: Ajmaline; Anti-Arrhythmia Agents; Bretylium Compounds; Catecholamines; Cell Membrane Permeability; Digitalis Glycosides; Heart Atria; Heart Ventricles; Humans; Oxprenolol; Phenytoin; Procainamide; Quinidine

1973

Trials

1 trial(s) available for quinidine and oxprenolol

ArticleYear
[Oxprenolol in the treatment and prevention of cardiac arrhythmias].
    Minerva medica, 1975, Oct-13, Volume: 66, Issue:68

    Topics: Adult; Aged; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Cardiac Complexes, Premature; Drug Evaluation; Female; Humans; Male; Middle Aged; Oxprenolol; Quinidine; Tachycardia

1975

Other Studies

17 other study(ies) available for quinidine and oxprenolol

ArticleYear
QSAR model for drug human oral bioavailability.
    Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13

    Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship

2000
Cheminformatic models to predict binding affinities to human serum albumin.
    Journal of medicinal chemistry, 2001, Dec-06, Volume: 44, Issue:25

    Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Chromatography, Affinity; Cyclooxygenase Inhibitors; Databases, Factual; Humans; Hydrophobic and Hydrophilic Interactions; Penicillins; Pharmaceutical Preparations; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Serum Albumin; Steroids

2001
Air to lung partition coefficients for volatile organic compounds and blood to lung partition coefficients for volatile organic compounds and drugs.
    European journal of medicinal chemistry, 2008, Volume: 43, Issue:3

    Topics: Air; Animals; Humans; Lung; Organic Chemicals; Probability; Rats; Tissue Distribution; Volatilization

2008
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
    Journal of medicinal chemistry, 2008, Oct-09, Volume: 51, Issue:19

    Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship

2008
Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domain.
    Bioorganic & medicinal chemistry, 2009, Oct-01, Volume: 17, Issue:19

    Topics: Antineoplastic Agents; Blood Proteins; Caco-2 Cells; Cell Membrane Permeability; Computer Simulation; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Phosphoproteins; Protein Binding; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-akt; Quantitative Structure-Activity Relationship

2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
    European journal of medicinal chemistry, 2010, Volume: 45, Issue:3

    Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical

2010
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
    Bioorganic & medicinal chemistry, 2010, Mar-15, Volume: 18, Issue:6

    Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics

2010
Measurement of unbound drug exposure in brain: modeling of pH partitioning explains diverging results between the brain slice and brain homogenate methods.
    Drug metabolism and disposition: the biological fate of chemicals, 2011, Volume: 39, Issue:3

    Topics: Animals; Biological Transport; Brain; Chemical Phenomena; Dialysis; Hydrogen-Ion Concentration; In Vitro Techniques; Lysosomes; Male; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Tissue Distribution

2011
QSAR-based permeability model for drug-like compounds.
    Bioorganic & medicinal chemistry, 2011, Apr-15, Volume: 19, Issue:8

    Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship

2011
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
    Pharmaceutical research, 2014, Volume: 31, Issue:4

    Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation

2014
Inhibitory effect of some membrane active drugs on RNA and DNA synthesis in cultured chick embryo liver cells.
    Biochemical and biophysical research communications, 1976, May-23, Volume: 76, Issue:2

    Topics: Adrenergic beta-Antagonists; Animals; Cells, Cultured; Chick Embryo; DNA; Kinetics; Lidocaine; Liver; Oxprenolol; Pindolol; Propranolol; Quinidine; RNA; Thymidine; Uridine

1976
Inhibitory effect of membrane active compounds on the uptake of 14C-alpha-aminoisobutyric acid (AIB) in cultured chick embryo liver cells.
    Life sciences, 1977, Aug-01, Volume: 21, Issue:3

    Topics: Adrenergic beta-Antagonists; Aminoisobutyric Acids; Animals; Chick Embryo; Lidocaine; Liver; Oxprenolol; Pindolol; Practolol; Propranolol; Quinidine

1977
[Various aspects of individualization of drug therapy of extrasystole].
    Kardiologiia, 1977, Volume: 17, Issue:4

    Topics: Administration, Oral; Adolescent; Adult; Aged; Anti-Arrhythmia Agents; Atropine; Belladonna Alkaloids; Cardiac Complexes, Premature; Drug Evaluation; Drug Therapy, Combination; Humans; Injections, Intravenous; Middle Aged; Oxprenolol; Potassium Magnesium Aspartate; Procainamide; Propranolol; Quinidine; Strophanthins; Verapamil

1977
Mechanism of action of antidysrhythmic drugs on ventricular conduction as studied with intramural electrodes.
    Advances in cardiology, 1975, Volume: 14

    Topics: Ajmaline; Animals; Disopyramide; Dogs; Electrocardiography; Heart Conduction System; Hydroxyzine; Lidocaine; Oxprenolol; Phenytoin; Propranolol; Purkinje Fibers; Quinidine; Verapamil

1975
Clinical aspects of the anti-arrhythmic actions of beta-receptor blocking drugs. 2. Clinical pharmacology.
    The New Zealand medical journal, 1973, Dec-26, Volume: 78, Issue:505

    Topics: Adrenergic beta-Antagonists; Alprenolol; Arrhythmias, Cardiac; Drug Therapy, Combination; Heart Failure; Humans; Oxprenolol; Pindolol; Practolol; Propranolol; Quinidine; Stereoisomerism; Structure-Activity Relationship

1973
The effects of -blocking drugs on atrioventricular conduction and contractility.
    Cardiology, 1971, Volume: 56, Issue:1

    Topics: Adrenergic beta-Antagonists; Animals; Dogs; Heart; Heart Conduction System; Oxprenolol; Propranolol; Quinidine; Sotalol; Sympatholytics

1971